Z-1486-2023 Class I Ongoing

Recalled by Cordis US Corp — Miami Lakes, FL

FDA device recall Z-1486-2023 was initiated by Cordis US Corp on Mar 24, 2023 and is designated Class I. Reason for recall: There is a potential for separation of the ANGIOGUARD RX / XP delivery system and capture sheath which include but are not limited to situations of an intra-procedural delay, unplanned percutaneous… The recall status is ongoing. Affected quantity: 54 units.

Recall details

Product Type
Devices
Report Date
May 17, 2023
Initiation Date
Mar 24, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
54 units

Product description

ANGIOGUARD RX / XP Emboli Capture Guidewire System, REF 701814RMC

Reason for recall

There is a potential for separation of the ANGIOGUARD RX / XP delivery system and capture sheath which include but are not limited to situations of an intra-procedural delay, unplanned percutaneous or surgical intervention, or stroke; while a replacement device is prepared.

Distribution pattern

Worldwide distribution.

Code information

UDI/DI 20705032056851; Lot Numbers: 35265661

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1486-2023
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1486-2023. Report a data issue: hello@regdatalab.com.